ISSN: 1428-2526
Contemporary Oncology
SCImago Journal & Country Rank

Detection of minimal residual disease in childhood acute lymphoblastic leukemia: technology and clinical applications

Anna B. Pawlowska

Współcz Onkol 2005, vol. 9: 4 (178-182)
At the time of achieving clinical remission, patients with acute lymphoblastic leukemia (ALL) may harbor up to 1010 residual leukemic blasts. Detection of these cells is beyond the sensitivity level of classical cytomorphologic methods; they represent Minimal Residual Disease (MRD). Sensitive techniques developed for MRD detection can better define the leukemic burden and detect the residual blasts at the 0.1-0.0001% level.
The most promising techniques for MRD monitoring are flow cytometric detection of aberrant immunophenotypes and polymerase chain reaction analysis of clonal antigen-receptor gene rearrangements. These techniques allow monitoring of MRD in almost all patients with pediatric ALL (up to 95%). In published clinical trials, MRD detection proved to be an excellent prognostic factor in the outcome of children with ALL. Evaluation of early treatment response allows for precise risk stratification that may lead to the tailoring of the treatment intensity and the reduction of long-term toxicities. Additionally, the detection of an increase in the MRD level enables one to anticipate an impending relapse. In this review, I discuss techniques used for MRD detection as well as the prognostic value of MRD monitoring during front-line treatment of childhood leukemia, during treatment of relapsed disease, and prior to bone marrow transplantation for ALL.

review, pediatric acute lymphoblastic leukemia, minimal residual disease, flow cytometry, polymerase chain reaction

Featured products
Bates – kieszonkowy przewodnik po badaniu podmiotowym i przedmiotowym
Lynn S. Bickley

prof. dr hab. n. med. Zbigniew Gaciong
dr n. med. Piotr Jędrusik

Format: 108x180
Liczba stron: 432
Oprawa: miękka
Cała prawda o e-papierosach

Jean-François Etter, Gérard Mathern

Format: 125x197 mm
Liczba stron: 208
Oprawa: miękka
Stany nagłe w onkologii. Występowanie i leczenie
pod redakcją Andrzeja W. Szawłowskiego i Grzegorza Wallnera
2 tomy

TOM I - Format: B5, liczba stron: 340, oprawa miękka
cena: 92.00 zł

TOM II - Format: B5, liczba stron: 444, oprawa miękka
cena: 92.00 zł

Kompendium postępowania w nowotworach wątroby
pod redakcją Krzysztofa Simona i Krzysztofa Krzemienieckiego

Format: A5
Liczba stron: 88
Oprawa: miękka
Studenci Medycyny i Farmacji
Portal adresowanych do studentów uczelni medycznych w Polsce i za granicą.
Copyright notice Privacy policy Advertising policy Contact us
Stosujemy się do standardu HONcode dla wiarygodnej informacji zdrowotnej This site complies with the HONcode standard for trustworthy health information: verify here
Created by Bentus
PayU - płatności internetowe